Literature DB >> 12680893

Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate.

J C Arévalo-Lorido, J Carretero-Gómez, J C Bureo-Dacal, C Montero-Leal, P Bureo-Dacal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680893      PMCID: PMC1884237          DOI: 10.1046/j.1365-2125.2003.01816.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  Anticonvulsant hypersensitivity syndrome.

Authors:  A L Licata; E D Louis
Journal:  Compr Ther       Date:  1996-03

2.  Anticonvulsant hypersensitivity syndrome.

Authors:  C C Vittorio; J J Muglia
Journal:  Arch Intern Med       Date:  1995-11-27

3.  Dilantin hypersensitivity syndrome imitating staphylococcal toxic shock.

Authors:  T Potter; F DiGregorio; M Stiff; K Hashimoto
Journal:  Arch Dermatol       Date:  1994-07

4.  Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine.

Authors:  O Cogrel; M Beylot-Barry; B Vergier; P Dubus; M S Doutre; J P Merlio; C Beylot
Journal:  Br J Dermatol       Date:  2001-06       Impact factor: 9.302

  4 in total
  4 in total

1.  Acute hypersensitivity syndrome caused by valproic Acid: a review of the literature and a case report.

Authors:  Robert G Bota; Allein P Ligasan; Tom G Najdowski; Andrei Novac
Journal:  Perm J       Date:  2011

2.  Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Authors:  X T Wu; P W Hong; D J Suolang; D Zhou; H Stefan
Journal:  Epilepsy Behav Case Rep       Date:  2017-06-20

3.  Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report.

Authors:  Mahboubeh Darban; Bahador Bagheri
Journal:  Iran Red Crescent Med J       Date:  2016-08-06       Impact factor: 0.611

4.  Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele.

Authors:  Kumi Sakurada; Takeshi Kozaru; Kazuo Yamada; Masashi Nibuya; Kiyoshi Nagata; Eiji Suzuki
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-04       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.